| scholarly article | Q13442814 |
| P50 | author | Xin-Yuan Guan | Q39845550 |
| John M. Luk | Q42935545 | ||
| P2093 | author name string | Suisui Dong | |
| Hongyue Dai | |||
| Nikki P Lee | |||
| Chunsheng Zhang | |||
| Mao Mao | |||
| Ronnie T P Poon | |||
| Felice H Tsang | |||
| Felix H Shek | |||
| P2860 | cites work | The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A) | Q24649859 |
| Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. | Q33302500 | ||
| Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy | Q33565483 | ||
| Independent roles of eIF5A and polyamines in cell proliferation. | Q40514139 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 968-976 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma | |
| P478 | volume | 127 |
| Q47306770 | A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers |
| Q34334378 | Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression |
| Q34988368 | Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma |
| Q35883784 | Biological Relevance and Therapeutic Potential of the Hypusine Modification System |
| Q38078237 | Biomarkers for predicting future metastasis of human gastrointestinal tumors. |
| Q36420885 | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. |
| Q47771443 | Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies |
| Q35627178 | Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage |
| Q36444280 | Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels |
| Q99630216 | Eukaryotic translation initiation factor 5A in the pathogenesis of cancers |
| Q41789947 | Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition |
| Q34395707 | Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies |
| Q38843125 | Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer |
| Q34035345 | Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome |
| Q42639936 | Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma |
| Q89847002 | Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity |
| Q35970141 | MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer |
| Q37062650 | MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. |
| Q49335206 | MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2. |
| Q38996944 | Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2. |
| Q92617390 | Prognostic significance of BZW2 expression in lung adenocarcinoma patients |
| Q39442425 | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. |
| Q38163977 | Roles of eukaryotic initiation factor 5A2 in human cancer. |
| Q58062853 | Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma |
| Q35808203 | Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma |
| Q36413366 | Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma |
| Q38881007 | Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer |
| Q38781000 | The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma |
| Q36519353 | The translation factor eIF5A and human cancer |
| Q26830163 | eIF5A isoforms and cancer: two brothers for two functions? |
| Q37448092 | eIF5A2 is an alternative pathway for cell proliferation in cetuximab-treated epithelial hepatocellular carcinoma |
Search more.